Top Tech Companies in Denver & Boulder, CO (6,101)

Strong Market Position & Advantage: Evidence indicates Hydrite sits in the North American top cohort for chemical distribution and is a leader among U.S. independents, with recognized niche strength in foam control and bisulfite chemistries. Awards from enterprise customers and repeated workplace recognitions support a reputation for reliability and execution.

Market Expansion: Evidence indicates acquisitions in 2024–2025 extended the footprint into the Southeast and toward coast‑to‑coast coverage, complemented by capacity investments in Iowa and Indiana. These moves broaden geographic reach and operational presence across key U.S. markets.

Product Line Growth: Evidence indicates portfolio breadth expanded through acquisitions in water treatment and polymers and a multi‑year distribution agreement for antimicrobial products. Program refreshes in food ingredients signal continued investment in higher‑value offerings.

Strong Market Position & Advantage: The company is repeatedly described as a leader in life‑sciences revenue management and compliance by its own materials and several third‑party profiles, indicating entrenched positioning in a defined niche. Scale markers such as managing over a trillion dollars of customer gross revenue and serving a large global enterprise base reinforce this advantage.

Customer Loyalty & Retention: Net revenue retention is characterized as high, pointing to expansion within existing accounts. Enterprise customers often commit at significant contract values, suggesting durable relationships in core verticals.

Innovation-Driven Growth: New offerings such as a real‑time analytics solution and accelerated AI initiatives signal ongoing platform investment. The acquisition of a 340B/gross‑to‑net specialist and targeted go‑to‑market moves expand capabilities and use cases within pharma and medtech.

Investor Backing & Capital Strength: The company controls a capital base exceeding $5–$6 billion, manages roughly 200 properties, and secured a $115 million senior loan for Texas assets. Partnerships with major institutional investors and a track record of recapitalizations indicate durable access to capital.

Strong Market Position & Advantage: Recognition as a Top 50 U.S. vertically integrated real estate firm and NMHC Top 50 owner underscores national credibility. Managing 40,000+ apartment units across multiple states with six regional offices supports meaningful operating scale.

Market Expansion: Unit counts and properties under management have increased versus prior years, and the firm continues acquisitions and stake-building in targets like Aimco. Recent transactions and refinancing across Texas assets signal ongoing activity and footprint growth.

Strong Market Position & Advantage: Havenly is positioned as the leading scale player in U.S. online interior design, reinforced by frequent industry recognition and share gains following competitor exits. Its hybrid model and acquisitions (such as Interior Define) strengthen an end-to-end offering that bridges online design with physical retail and manufacturing.

Market Expansion: The company has broadened from e-design into a multi-brand home-furnishings platform through multiple acquisitions and omnichannel expansion. Recent moves, including acquiring The Expert and launching an in-house rug brand, indicate continued expansion of reach and offerings.

Investor Backing & Capital Strength: The business has raised tens of millions across multiple rounds, including a notable Series C, from institutional investors to fuel growth. This capital has supported M&A and technology investments such as designer-trained AI and 3D visualization.

Strong Market Position & Advantage: Regulators, company filings, and independent coverage characterize Henry Schein as a top full‑service dental distributor with global scale and Fortune 500 standing. Its role in an FTC‑recognized oligopoly and breadth across distribution and software reinforce durable competitive advantages.

Resilient & Sustainable Growth: Recent results indicate steady year‑over‑year increases in sales and EPS, and management has reaffirmed guidance for modest top‑line and EBITDA growth. Share repurchases and a multi‑year operating‑income improvement program support a measured compounding profile.

Future-Ready Strategy: The company is investing in higher‑growth technology and value‑added services and pursuing AI‑enabled initiatives alongside a defined multi‑year operating plan. Portfolio moves in software, digital solutions, and specialty offerings are positioned to create switching costs and embed workflows in practices.

Strong Market Position & Advantage: Arcadis holds top-tier positions across multiple segments, including leadership in semiconductors, pharma, and hazardous waste, and top-three standing in data centers and power. Scale, global footprint, and repeated top-tier ENR/WA100 placements underscore a durable market advantage.

Resilient & Sustainable Growth: Organic growth turned positive in 2026 and guidance was raised to low-single-digit growth, while a record €4.0B backlog and 1.16x book-to-bill signal demand outpacing revenues. Order intake up 13.5% organically supports a pipeline for continued expansion.

Future-Ready Strategy: Resources are being shifted toward structurally growing arenas such as water, energy/power, climate adaptation, data centers/technology, life sciences, and major infrastructure. This repositioning suggests a strategy aligned with long-duration demand drivers.

Strong Market Position & Advantage: Repeated UCaaS Leader placements by Gartner through 2024/2025 and third-party data citing #1 UCaaS share by revenue and seats underscore a durable position in core UCaaS. High scores in Gartner Critical Capabilities and continued presence on enterprise short lists reinforce perceived competitive strength.

Healthy Cash Flow: Free cash flow increased year over year in early 2026 with guidance raised to $615M–$625M, alongside GAAP operating margin expansion. Dividend initiation and a subsequent ~67% hike, plus repaid 2026 notes and no maturities until 2030, signal confidence in ongoing cash generation.

Strategic Partnerships: Exclusive UCaaS partnership with Mitel and the ongoing Avaya relationship expand distribution and migrations from on-premises systems. An expanded two-way partnership with NICE in 2026 for integrated UCaaS/CCaaS further amplifies ecosystem reach.

Strong Revenue Growth: Fundraising through ALSAC is bringing in multi‑billion‑dollar annual support, enabling the institution to sustain operating costs and expand its mission scope.

Future-Ready Strategy: A $12.9 billion FY22–27 strategic plan targets scaled patient care, research expansion, and international initiatives, indicating long-term, proactive positioning.

Product Line Growth: Expanded research areas, new clinical and research facilities, and broader global initiatives reflect a widening set of programs and capabilities.

Investor Backing & Capital Strength: Recent investment by Blackstone of up to €250 million in December 2024 provides growth capital and signals external confidence in the firm’s expansion plans. Company statements link this funding to accelerating U.S. growth, M&A, and AI-enabled offerings.

Market Expansion: Multiple acquisitions and a sustained U.S. push (e.g., Notion Consulting, Ready Set Rocket, Precedence, Kaiser Associates) indicate ongoing geographic and service-line expansion across North America and Europe. Leadership attention to the U.S. market and a growing office footprint suggest increased depth in key geographies.

Innovation-Driven Growth: The firm is productizing AI (e.g., SiaGPT and 800+ deployable AI agents by April 2026) and launching new lines like Corporate Strategy, PE & M&A, pointing to growth via differentiated, tech-enabled delivery. Partnerships and ecosystem recognition around NVIDIA and AWS reinforce momentum in AI-driven consulting.

Strong Brand Reputation: Industry recognition such as Agency of the Year (2025 Healthcare Marketing Impact Awards) and repeated top-20 placements in MM+M’s Agency 100 signal a well-regarded brand within U.S. healthcare marketing. These markers reflect sustained credibility and visibility in its niche.

Innovation-Driven Growth: Launches of AI-powered operating models (e.g., the Humanity Suite) and an “AIgency” approach indicate a deliberate push to scale through technology and productized solutions. Evidence of platformization underscores continued investment in new, AI-enabled offerings.

Strategic Partnerships: Ecosystem partnerships and marketplace listings are expanding distribution of AI-powered services. These arrangements suggest an intentional strategy to widen reach via partner channels.